LCM
IBER.U

Landscape Capital Management’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Landscape Capital Management’s Portfolio IBER.U Stock Details IBER.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,568
Closed -$366K – 967
2022
Q4 		$366K Hold
36,568
– – 0.05% 335
2022
Q3 		$363K Hold
36,568
– – 0.05% 382
2022
Q2 		$359K Hold
36,568
– – 0.05% 358
2022
Q1 		$361K Sell
36,568
-1
-0% -$10 0.05% 352
2021
Q4 		$366K Hold
36,569
– – 0.05% 286
2021
Q3 		$366K Hold
36,569
– – 0.05% 304
2021
Q2 		$368K Buy
36,569
+10,856
+42% +$109K 0.05% 313
2021
Q1 		$254K Buy
+25,713
New +$257K 0.04% 287

Landscape Capital Management's IBER.U Position: Q1 2023 in Review

Landscape Capital Management sold out of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) in Q1 2023, closing a stake of 36,568 shares — an estimated $366K sold.

Landscape Capital Management first reported a position in IBER.U in Q1 2021 and held it in 8 quarters. The position peaked at $368K in Q2 2021. 0 funds tracked by Wall St. Rank hold IBER.U as of Q1 2023.

  • Landscape Capital Management reported no remaining Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position as of Q1 2023 after selling out during the quarter.
  • Landscape Capital Management sold 36,568 Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant shares in Q1 2023, an estimated $366K.
  • Landscape Capital Management first reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in Q1 2021 and held it in 8 quarters.
  • Landscape Capital Management's Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position peaked at $368K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant as of Q1 2023.

Based on Landscape Capital Management's 13F filing for Q1 2023, filed 10 May 2023.